J2 Capital Management Inc

Position in GSK — GSK plc

CIK 1586882 TROY, MI

Position in GSK

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$594,337

-$109,445 QoQ

Shares Held

11,338

-11.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.32%

of 13F equity value

Holder Rank

#446

of 1,033 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

J2 Capital Management Inc holds $5,355,034 across 6 Drug Manufacturers - General names. GSK ranks #5 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,224	$1,817,847
2	LLY	ELI LILLY & Co	824	$988,330
3	MRK	Merck & Co., Inc.	6,147	$789,889
4	JNJ	Johnson & Johnson	2,765	$702,227
5	GSK	GSK plc This page	11,338	$594,337
6	GILD	Gilead Sciences, Inc.	3,660	$462,404

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$594,337	11,338	-11.1%	Shares	Sole	2026-07-20
2026-03-31	$703,782	12,752	-3.4%	Shares	Sole	2026-04-21
2025-12-31	$647,082	13,195	-3.2%	Shares	Sole	2026-01-20
2025-09-30	$588,098	13,626	-1.1%	Shares	Sole	2025-10-14
2025-06-30	$529,228	13,782	+0.7%	Shares	Sole	2025-07-21
2025-03-31	$530,079	13,683	-22.3%	Shares	Sole	2025-04-08
2024-12-31	$595,671	17,613	+5.7%	Shares	Sole	2025-01-15
2023-09-30	$603,997	16,662	+0.2%	Shares	Sole	2023-10-11
2023-06-30	$592,907	16,636	+10.3%	Shares	Sole	2023-07-17
2023-03-31	$536,831	15,088	+3.6%	Shares	Sole	2023-04-18
2022-12-31	$511,884	14,567	+4.0%	Shares	Sole	2023-01-17
2022-09-30	$412,284	14,009	+135.5%	Shares	Sole	2022-10-17
2022-06-30	$253,945	5,948	-24.1%	Shares	Sole	2022-07-19
2022-03-31	$334,654	7,833	-10.3%	Shares	Sole	2022-04-21
2021-12-31	$377,774	8,734	—	Shares	Sole	2022-01-21
No filing history on record for this holder in this stock.